Showing results (31-40 of 238) with videos related to
Sort By:
Pageof 24
Expert Opinion on Pharmacotherapy|July 18, 2019
New developments in pharmacotherapy for Friedreich ataxiaAlexandra Clay, Patrick Hearle, Kim Schadt, et al.Seminars in Pediatric Neurology|May 9, 2018
Pediatric Ataxia: Focus on Chronic DisordersDavid R Lynch, Ashley McCormick, Kimberly Schadt, et al.Annals of Clinical and Translational Neurology|December 26, 2014
Pediatric anti-NMDA receptor encephalitis is seasonalLaura A Adang, David R Lynch, Jessica A PanzerExpert Review of Neurotherapeutics|July 19, 2014
Therapeutic approaches for the treatment of Friedreich's ataxiaCassandra J Strawser, Kimberly A Schadt, David R LynchJournal of Neuroimmunology|August 24, 2015
Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndromeJessica A Panzer, Ronan Anand, Josep Dalmau, et al.Journal of the Neurological Sciences|May 14, 2014
Cross-sectional analysis of glucose metabolism in Friedreich ataxiaNathaniel R Greeley, Sean Regner, Steve Willi, et al.Neuroscience Letters|November 5, 2018
Neuronal serine racemase associates with Disrupted-In-Schizophrenia-1 and DISC1 agglomerates: Implications for schizophreniaAriel A Jacobi, Sarah Halawani, David R Lynch, et al.Expert Opinion on Investigational Drugs|January 28, 2023
Omaveloxolone: an activator of Nrf2 for the treatment of Friedreich ataxiaVictoria Profeta, Kellie McIntyre, McKenzie Wells, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 28, 2014
Usefulness of frataxin immunoassays for the diagnosis of Friedreich ataxiaEric C Deutsch, Devin Oglesbee, Nathaniel R Greeley, et al.Neurology. Genetics|August 29, 2025
Genetic and Phenotypic Variability in Siblings With Friedreich AtaxiaKhashayar Eshaghi, Prima H Rao, Megan M Shen, et al.Pageof 24